Fundraising Fox

Chirality Biosciences

Farmingdale, US · Founded 2023 · Delaware corporation

Chirality develops a proprietary chiral separation technology to produce higher-purity, safer pharmaceutical compounds with less waste than conventional methods like HPLC. It serves scientists and pharmaceutical manufacturers seeking faster, cleaner paths to drug production.

Founders & leadership

AG
Arielle GabalskiExecutive
JJ
Joanna Jennings EagleExecutive

Board

RK
Robert KaytonBoard director

Reported raises · per SEC filings

Form D private placements

$3.1M disclosed across 1 round · 2025

$3.1MraisedOct 2025 · 9 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Arielle GabalskiExecutive Officer, Director
  • Robert KaytonDirector
  • Joanna Jennings EagleExecutive Officer
Offering amount
$4.1M
Amount sold
$3.1M
First sale
Oct 2025
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Chirality Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Chirality Biosciences do?
Chirality develops a proprietary chiral separation technology to produce higher-purity, safer pharmaceutical compounds with less waste than conventional methods like HPLC. It serves scientists and pharmaceutical manufacturers seeking faster, cleaner paths to drug production.
How much funding has Chirality Biosciences raised?
Chirality Biosciences has disclosed $3.1M raised across 1 round.
Where is Chirality Biosciences headquartered?
Chirality Biosciences is headquartered in Farmingdale, US.